Search results
Merck Reports Progress On The Cancer Front As It Prepares For Keytruda Patent Expiration
Benzinga via AOL· 1 month agoAfter topping expectations with first quarter revenue and adjusted earnings last week, Merck & Co...
A Bull Market Is Here: 2 Stocks to Buy and Hold for 10 Years
Motley Fool via Yahoo Finance· 5 months agoWith the S&P 500 index recently hitting a new all-time high, we can officially declare that we are...
Q3 Earnings Season Scorecard and Analyst Reports for Merck, Bank of America & AMD
Zacks via Yahoo Finance· 7 months agoThursday, November 2, 2023 The Zacks Research Daily presents the best research output of our analyst...
The Case for Buying Iovance Biotherapeutics Stock Just Got Even Better. Here's Why
Motley Fool via Yahoo Finance· 5 days agoIt's always a nice surprise to see that a company you're invested in is making good on its...
The Zacks Analyst Blog Highlights J&J, AstraZeneca, Merck, Seagen and Pfizer
Zacks via Yahoo Finance· 1 year agoFor Immediate Release Chicago, IL – April 10, 2023 – Zacks.com announces the list of stocks featured...
The Zacks Analyst Blog Highlights Merck, Bank of America, AMD, Netflix and Union Pacific
Zacks via Yahoo Finance· 7 months agoFor Immediate Release Chicago, IL – November 3, 2023 – Zacks.com announces the list of stocks...
The Zacks Analyst Blog Highlights Archer-Daniels-Midland, McKesson, Marathon Petroleum, Exxon Mobil...
Zacks via Yahoo Finance· 2 years agoFor Immediate Release Chicago, IL – November 23, 2022 – Zacks.com announces the list of stocks...
Merck's Deal With Seagen May Have Fallen Through. Now What?
Motley Fool· 2 years agoFollowing months of speculation over pharmaceutical giant Merck's (NYSE: MRK) potential takeover of cancer-focused biotech Seagen (NASDAQ: SGEN), reports are now surfacing that the two companies ...
Patients seek relief from spiraling drug prices. Will the Inflation Reduction Act deliver?
USA TODAY via Yahoo News· 2 years agoJackie Trapp has incurable blood cancer and takes a chemotherapy drug that cost more than $240,000...
Pfizer Surprises With Profit But Revolutionizing Cancer Treatment Is Its Best Chance Of Getting Back...
Benzinga via Yahoo Finance· 4 months agoOn Tuesday, Pfizer Inc (NYSE: PFE) reported mixed results for its fourth quarter. Last year, Pfizer...